id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0369-0743,FDA,FDA-2007-D-0369,Request for Extension from King & Spalding,Other,Request for Extension,2022-12-13T05:00:00Z,2022,12,2022-12-13T05:00:00Z,,2022-12-13T19:02:41Z,,0,0,090000648553435b
FDA-2007-D-0369-0699,FDA,FDA-2007-D-0369,PSG_019726 - Draft Guidance on Goserelin acetate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:16Z,,1,0,09000064854d1eb8
FDA-2007-D-0369-0698,FDA,FDA-2007-D-0369,PSG_019488 - Draft Guidance on Nicardipine Hydrochloride,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:16Z,,1,0,09000064854d1eb6
FDA-2007-D-0369-0711,FDA,FDA-2007-D-0369,PSG_021526 - Draft Guidance on Ranolazine,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:28Z,,1,0,09000064854d2041
FDA-2007-D-0369-0721,FDA,FDA-2007-D-0369,PSG_207962 - Draft Guidance on Lidocaine,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:31Z,,1,0,09000064854d2065
FDA-2007-D-0369-0718,FDA,FDA-2007-D-0369,PSG_203791 - Draft Guidance on Acyclovir,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:29Z,,1,0,09000064854d2051
FDA-2007-D-0369-0726,FDA,FDA-2007-D-0369,PSG_211172 - Draft Guidance on Inotersen Sodium,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:33Z,,1,0,09000064854d207f
FDA-2007-D-0369-0704,FDA,FDA-2007-D-0369,PSG_020701 - Draft Guidance on Progesterone,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:17Z,,1,0,09000064854d1f74
FDA-2007-D-0369-0700,FDA,FDA-2007-D-0369,PSG_020080-Autoinj - Draft Guidance on Sumatriptan Succinate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:17Z,,1,0,09000064854d1eba
FDA-2007-D-0369-0732,FDA,FDA-2007-D-0369,PSG_213716 - Draft Guidance on Voclosporin,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:31Z,,1,0,09000064854d206b
FDA-2007-D-0369-0710,FDA,FDA-2007-D-0369,PSG_021361 - Draft Guidance on Rifaximin,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:29Z,,1,0,09000064854d2055
FDA-2007-D-0369-0722,FDA,FDA-2007-D-0369,PSG_208090 - Draft Guidance on Oxycodone,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:30Z,,1,0,09000064854d205d
FDA-2007-D-0369-0737,FDA,FDA-2007-D-0369,PSG_214200 - Draft Guidance on Trilaciclib Dihydrochloride,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:32Z,,1,0,09000064854d2079
FDA-2007-D-0369-0723,FDA,FDA-2007-D-0369,PSG_208843 - Draft Guidance on Hydroxyurea,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:29Z,,1,0,09000064854d204f
FDA-2007-D-0369-0740,FDA,FDA-2007-D-0369,PSG_215712 - Draft Guidance on Mometasone Furoate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:30Z,,1,0,09000064854d2063
FDA-2007-D-0369-0709,FDA,FDA-2007-D-0369,PSG_021066 - Draft Guidance on Ketotifen fumarate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:28Z,,1,0,09000064854d203b
FDA-2007-D-0369-0729,FDA,FDA-2007-D-0369,PSG_213135 - Draft Guidance on Magnesium Sulfate; Potassium Chloride; Sodium Sulfate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:29Z,,1,0,09000064854d2057
FDA-2007-D-0369-0742,FDA,FDA-2007-D-0369,PSG_216018 - Draft Guidance on Ranolazine,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:30Z,,1,0,09000064854d205b
FDA-2007-D-0369-0739,FDA,FDA-2007-D-0369,PSG_215650 - Draft Guidance on Clindamycin Phosphate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:31Z,,1,0,09000064854d206f
FDA-2007-D-0369-0716,FDA,FDA-2007-D-0369,PSG_078878 - Draft Guidance on Omeprazole Magnesium,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:33Z,,1,0,09000064854d2081
FDA-2007-D-0369-0714,FDA,FDA-2007-D-0369,PSG_022059 - Draft Guidance on Lapatinib Ditosylate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:28Z,,1,0,09000064854d203f
FDA-2007-D-0369-0717,FDA,FDA-2007-D-0369,PSG_202057 - Draft Guidance on Icosapent Ethyl,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:29Z,,1,0,09000064854d2059
FDA-2007-D-0369-0728,FDA,FDA-2007-D-0369,PSG_212904 - Draft Guidance on Tivozanib Hydrochloride,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:32Z,,1,0,09000064854d207d
FDA-2007-D-0369-0702,FDA,FDA-2007-D-0369,PSG_020508 - Draft Guidance on Ammonium Lactate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:08Z,,1,0,09000064854d2699
FDA-2007-D-0369-0712,FDA,FDA-2007-D-0369,PSG_021825 - Draft Guidance on Deferiprone,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:27Z,,1,0,09000064854d0dd6
FDA-2007-D-0369-0731,FDA,FDA-2007-D-0369,PSG_213498 - Draft Guidance on Ponesimod,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:28Z,,1,0,09000064854d2043
FDA-2007-D-0369-0735,FDA,FDA-2007-D-0369,PSG_214096 - Draft Guidance on Tepotinib Hydrochloride,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:30Z,,1,0,09000064854d2061
FDA-2007-D-0369-0695,FDA,FDA-2007-D-0369,PSG_017441 - Draft Guidance on Ferric Oxyhydroxide,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:16Z,,1,0,09000064854d1d1a
FDA-2007-D-0369-0741,FDA,FDA-2007-D-0369,PSG_215935 - Draft Guidance on Budesonide,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:32Z,,1,0,09000064854d2073
FDA-2007-D-0369-0724,FDA,FDA-2007-D-0369,PSG_208845 - Draft Guidance on Triamcinolone Acetonide,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:32Z,,1,0,09000064854d207b
FDA-2007-D-0369-0705,FDA,FDA-2007-D-0369,PSG_020955 - Draft Guidance on Ferric Oxyhydroxide,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:08Z,,1,0,09000064854d269e
FDA-2007-D-0369-0727,FDA,FDA-2007-D-0369,PSG_212269 - Draft Guidance on Deferiprone,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:30Z,,1,0,09000064854d205f
FDA-2007-D-0369-0701,FDA,FDA-2007-D-0369,PSG_020080-Vial - Draft Guidance on Sumatriptan Succinate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:17Z,,1,0,09000064854d1ebc
FDA-2007-D-0369-0703,FDA,FDA-2007-D-0369,PSG_020578 - Draft Guidance on Goserelin acetate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:17Z,,1,0,09000064854d1f72
FDA-2007-D-0369-0693,FDA,FDA-2007-D-0369,Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,Notice,Notice of Availability,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,,2023-02-17T15:36:29Z,2022-25210,0,0,09000064854d0520
FDA-2007-D-0369-0713,FDA,FDA-2007-D-0369,"PSG_021892 - Draft Guidance on Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate",Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:28Z,,1,0,09000064854d203d
FDA-2007-D-0369-0719,FDA,FDA-2007-D-0369,PSG_206488 - Draft Guidance on Eteplirsen,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:31Z,,1,0,09000064854d2067
FDA-2007-D-0369-0734,FDA,FDA-2007-D-0369,PSG_214018 - Draft Guidance on Fosdenopterin Hydrobromide,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:31Z,,1,0,09000064854d2069
FDA-2007-D-0369-0725,FDA,FDA-2007-D-0369,PSG_210922 - Draft Guidance on Patisiran Sodium,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:29Z,,1,0,09000064854d2053
FDA-2007-D-0369-0736,FDA,FDA-2007-D-0369,PSG_214154 - Draft Guidance on Drospirenone; Estetrol,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:32Z,,1,0,09000064854d2077
FDA-2007-D-0369-0696,FDA,FDA-2007-D-0369,PSG_017769 - Draft Guidance on Calcitonin Salmon,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:16Z,,1,0,09000064854d1d1c
FDA-2007-D-0369-0706,FDA,FDA-2007-D-0369,PSG_020958 - Draft Guidance on Calcium Carbonate; Famotidine; Magnesium Hydroxide,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:17Z,,1,0,09000064854d1f7a
FDA-2007-D-0369-0707,FDA,FDA-2007-D-0369,PSG_021026 - Draft Guidance on Miconazole Nitrate; White Petrolatum; Zinc Oxide,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-07T00:43:17Z,,1,0,09000064854d1fed
FDA-2007-D-0369-0715,FDA,FDA-2007-D-0369,PSG_050704 - Draft Guidance on Daunorubicin Citrate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:28Z,,1,0,09000064854d0dd8
FDA-2007-D-0369-0697,FDA,FDA-2007-D-0369,PSG_019155 - Draft Guidance on Ammonium Lactate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:08Z,,1,0,09000064854d2544
FDA-2007-D-0369-0708,FDA,FDA-2007-D-0369,PSG_021065 - Draft Guidance on Ethinyl Estradiol; Norethindrone Acetate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:27Z,,1,0,09000064854d0dd4
FDA-2007-D-0369-0738,FDA,FDA-2007-D-0369,PSG_214383 - Draft Guidance on Melphalan Flufenamide Hydrochloride,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:31Z,,1,0,09000064854d2071
FDA-2007-D-0369-0720,FDA,FDA-2007-D-0369,PSG_207924 - Draft Guidance on Baricitinib,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:33Z,,1,0,09000064854d2083
FDA-2007-D-0369-0730,FDA,FDA-2007-D-0369,PSG_213138 - Draft Guidance on Fidaxomicin,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:31Z,,1,0,09000064854d206d
FDA-2007-D-0369-0733,FDA,FDA-2007-D-0369,PSG_213978 - Draft Guidance on Varenicline Tartrate,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:32Z,,1,0,09000064854d2075
FDA-2007-D-0369-0694,FDA,FDA-2007-D-0369,PSG_016199 - Draft Guidance on Hydrocortisone,Other,Guidance,2022-11-18T05:00:00Z,2022,11,2022-11-18T05:00:00Z,2023-04-19T03:59:59Z,2024-11-12T23:47:08Z,,1,0,09000064854d2540
FDA-2007-D-0369-0692,FDA,FDA-2007-D-0369,"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;
Availability",Notice,Notice of Availability,2022-10-24T04:00:00Z,2022,10,2022-10-24T04:00:00Z,,2022-10-24T17:57:15Z,2022-23015,0,0,090000648544cb99
FDA-2007-D-0369-0660,FDA,FDA-2007-D-0369,Draft Guidance on Technetium Tc-99m Sodium Pertechnetate Generator- PSG_202158,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:20Z,,1,0,090000648520a044
FDA-2007-D-0369-0664,FDA,FDA-2007-D-0369,Draft Guidance on Cobicistat; Darunavir; Emtricitabine; Tenofovir Alafenamide Fumarate - PSG_210455,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:20Z,,1,0,090000648520a04c
FDA-2007-D-0369-0670,FDA,FDA-2007-D-0369,Draft Guidance on Acetaminophen; Ibuprofen - PSG_211733,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:21Z,,1,0,090000648520a058
FDA-2007-D-0369-0673,FDA,FDA-2007-D-0369,Draft Guidance on Cabotegravir Sodium - PSG_212887,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:22Z,,1,0,090000648520a05e
FDA-2007-D-0369-0637,FDA,FDA-2007-D-0369,Draft Guidance on Ketoprofen - PSG_018754,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:16Z,,1,0,09000064852092e0
FDA-2007-D-0369-0652,FDA,FDA-2007-D-0369,Draft Guidance on Olopatadine Hydrochloride - PSG_021861,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:19Z,,1,0,090000648520a01b
FDA-2007-D-0369-0658,FDA,FDA-2007-D-0369,Draft Guidance on Dantrolene Sodium - PSG_205579,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:19Z,,1,0,090000648520a027
FDA-2007-D-0369-0666,FDA,FDA-2007-D-0369,Draft Guidance on Cytarabine; Daunorubicin - PSG_209401,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:21Z,,1,0,090000648520a050
FDA-2007-D-0369-0643,FDA,FDA-2007-D-0369,Draft Guidance on Lamotrigine - PSG_020764,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:17Z,,1,0,090000648520a009
FDA-2007-D-0369-0681,FDA,FDA-2007-D-0369,Draft Guidance on Dasiglucagon Hydrochloride - PSG_214231,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:23Z,,1,0,090000648520a08d
FDA-2007-D-0369-0649,FDA,FDA-2007-D-0369,Draft Guidance on Lanthanum Carbonate - PSG_021468,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:18Z,,1,0,090000648520a015
FDA-2007-D-0369-0654,FDA,FDA-2007-D-0369,Draft Guidance on Amoxicillin; Clavulanate Potassium - PSG_050726,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:19Z,,1,0,090000648520a01f
FDA-2007-D-0369-0674,FDA,FDA-2007-D-0369,Draft Guidance on Vibegron - PSG_213006,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:22Z,,1,0,090000648520a07f
FDA-2007-D-0369-0680,FDA,FDA-2007-D-0369,Draft Guidance on Azelastine Hydrochloride - PSG_213872,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:23Z,,1,0,090000648520a08b
FDA-2007-D-0369-0684,FDA,FDA-2007-D-0369,Draft Guidance on Cyclosporine - PSG_214965,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:23Z,,1,0,090000648520a093
FDA-2007-D-0369-0640,FDA,FDA-2007-D-0369,Draft Guidance on Medroxyprogesterone Acetate - PSG_012541,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:16Z,,1,0,090000648520a003
FDA-2007-D-0369-0663,FDA,FDA-2007-D-0369,Draft Guidance on Meloxicam - PSG_210583,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:20Z,,1,0,090000648520a04a
FDA-2007-D-0369-0644,FDA,FDA-2007-D-0369,Draft Guidance on Famotidine - PSG_020801,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:17Z,,1,0,090000648520a00b
FDA-2007-D-0369-0651,FDA,FDA-2007-D-0369,Draft Guidance on Cetirizine Hydrochloride - PSG_021621,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:18Z,,1,0,090000648520a019
FDA-2007-D-0369-0657,FDA,FDA-2007-D-0369,Draft Guidance on Ampicillin/Ampicillin Trihydrate - PSG_064082,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:19Z,,1,0,090000648520a025
FDA-2007-D-0369-0656,FDA,FDA-2007-D-0369,Draft Guidance on Ethinyl Estradiol; Norethindrone Acetate - PSG_203667,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:19Z,,1,0,090000648520a023
FDA-2007-D-0369-0662,FDA,FDA-2007-D-0369,Draft Guidance on Tacrolimus - PSG_210115,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:20Z,,1,0,090000648520a048
FDA-2007-D-0369-0672,FDA,FDA-2007-D-0369,Draft Guidance on Nifurtimox - PSG_213464,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:21Z,,1,0,090000648520a05c
FDA-2007-D-0369-0676,FDA,FDA-2007-D-0369,Draft Guidance on Vericiguat - PSG_214377,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:22Z,,1,0,090000648520a083
FDA-2007-D-0369-0668,FDA,FDA-2007-D-0369,Draft Guidance on Upadacitinib - PSG_211675,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:21Z,,1,0,090000648520a054
FDA-2007-D-0369-0669,FDA,FDA-2007-D-0369,Draft Guidance on Loteprednol Etabonate - PSG_210933,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:21Z,,1,0,090000648520a056
FDA-2007-D-0369-0677,FDA,FDA-2007-D-0369,Draft Guidance on Setmelanotide Acetate - PSG_213793,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:22Z,,1,0,090000648520a085
FDA-2007-D-0369-0682,FDA,FDA-2007-D-0369,Draft Guidance on Relugolix - PSG_214621,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:23Z,,1,0,090000648520a08f
FDA-2007-D-0369-0638,FDA,FDA-2007-D-0369,Draft Guidance on Ibuprofen - PSG_020601,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:16Z,,1,0,09000064852092e2
FDA-2007-D-0369-0648,FDA,FDA-2007-D-0369,Draft Guidance on Methylphenidate Hydrochloride - PSG_021475,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:18Z,,1,0,090000648520a013
FDA-2007-D-0369-0665,FDA,FDA-2007-D-0369,Draft Guidance on Oxymetazoline Hydrochloride; Tetracaine Hydrochloride - PSG_208032,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:20Z,,1,0,090000648520a04e
FDA-2007-D-0369-0679,FDA,FDA-2007-D-0369,Draft Guidance on Lonafarnib - PSG_213969,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:23Z,,1,0,090000648520a089
FDA-2007-D-0369-0659,FDA,FDA-2007-D-0369,Draft Guidance on Prednisone - PSG_202020,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:20Z,,1,0,090000648520a042
FDA-2007-D-0369-0671,FDA,FDA-2007-D-0369,Draft Guidance on Gallium Ga-68 Gozetotide - PSG_212642,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:21Z,,1,0,090000648520a05a
FDA-2007-D-0369-0639,FDA,FDA-2007-D-0369,Draft Guidance on Medroxyprogesterone Acetate - PSG_020246,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:16Z,,1,0,090000648520a001
FDA-2007-D-0369-0641,FDA,FDA-2007-D-0369,Draft Guidance on Carbamazepine - PSG_018281,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:17Z,,1,0,090000648520a005
FDA-2007-D-0369-0642,FDA,FDA-2007-D-0369,Draft Guidance on Loperamide Hydrochloride; Simethicone - PSG_020606,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:17Z,,1,0,090000648520a007
FDA-2007-D-0369-0653,FDA,FDA-2007-D-0369,Draft Guidance on Etonogestrel - PSG_021529,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:19Z,,1,0,090000648520a01d
FDA-2007-D-0369-0667,FDA,FDA-2007-D-0369,Draft Guidance on Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate - PSG_210526,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:21Z,,1,0,090000648520a052
FDA-2007-D-0369-0678,FDA,FDA-2007-D-0369,Draft Guidance on Berotralstat Hydrochloride - PSG_214094,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:22Z,,1,0,090000648520a087
FDA-2007-D-0369-0683,FDA,FDA-2007-D-0369,Draft Guidance on Pafolacianine Sodium - PSG_214907,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:23Z,,1,0,090000648520a091
FDA-2007-D-0369-0655,FDA,FDA-2007-D-0369,Draft Guidance on Loratadine - PSG_021891,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:19Z,,1,0,090000648520a021
FDA-2007-D-0369-0645,FDA,FDA-2007-D-0369,Draft Guidance on Caspofungin Acetate - PSG_021227,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:17Z,,1,0,090000648520a00d
FDA-2007-D-0369-0647,FDA,FDA-2007-D-0369,Draft Guidance on Caspofungin Acetate - PSG_021227,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:17Z,,1,0,090000648520a011
FDA-2007-D-0369-0661,FDA,FDA-2007-D-0369,Draft Guidance on Doxycycline Hyclate - PSG_050751,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:20Z,,1,0,090000648520a046
FDA-2007-D-0369-0636,FDA,FDA-2007-D-0369,Draft Guidance on Azelastine Hydrochloride - PSG_020114,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:16Z,,1,0,09000064852092de
FDA-2007-D-0369-0646,FDA,FDA-2007-D-0369,Draft Guidance on Nicotine - PSG_020385,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:17Z,,1,0,090000648520a00f
FDA-2007-D-0369-0675,FDA,FDA-2007-D-0369,Draft Guidance on Mometasone Furoate; Olopatadine Hydrochloride - PSG_211746,Other,Guidance,2022-08-05T04:00:00Z,2022,8,2022-08-05T04:00:00Z,2022-10-04T03:59:59Z,2024-11-07T00:41:22Z,,1,0,090000648520a081